Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

USA - NYSE:CSTM - FR0013467479 - Common Stock

15.52 USD
-0.84 (-5.13%)
Last: 9/19/2025, 2:17:57 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CSTM. CSTM was compared to 156 industry peers in the Metals & Mining industry. While CSTM is still in line with the averages on profitability rating, there are concerns on its financial health. CSTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CSTM had positive earnings in the past year.
In the past year CSTM had a positive cash flow from operations.
Of the past 5 years CSTM 4 years were profitable.
In the past 5 years CSTM always reported a positive cash flow from operatings.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

The Return On Assets of CSTM (2.44%) is better than 65.38% of its industry peers.
With an excellent Return On Equity value of 16.83%, CSTM belongs to the best of the industry, outperforming 89.74% of the companies in the same industry.
CSTM's Return On Invested Capital of 11.15% is amongst the best of the industry. CSTM outperforms 86.54% of its industry peers.
CSTM had an Average Return On Invested Capital over the past 3 years of 8.33%. This is below the industry average of 12.92%.
The last Return On Invested Capital (11.15%) for CSTM is above the 3 year average (8.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.44%
ROE 16.83%
ROIC 11.15%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

The Profit Margin of CSTM (0.99%) is better than 62.18% of its industry peers.
CSTM's Profit Margin has declined in the last couple of years.
CSTM has a Operating Margin of 3.72%. This is comparable to the rest of the industry: CSTM outperforms 55.13% of its industry peers.
CSTM's Operating Margin has declined in the last couple of years.
CSTM's Gross Margin of 12.18% is in line compared to the rest of the industry. CSTM outperforms 46.15% of its industry peers.
In the last couple of years the Gross Margin of CSTM has grown nicely.
Industry RankSector Rank
OM 3.72%
PM (TTM) 0.99%
GM 12.18%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CSTM is still creating some value.
The number of shares outstanding for CSTM has been reduced compared to 1 year ago.
Compared to 5 years ago, CSTM has more shares outstanding
The debt/assets ratio for CSTM is higher compared to a year ago.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.25 indicates that CSTM is not in any danger for bankruptcy at the moment.
CSTM has a Altman-Z score of 3.25. This is comparable to the rest of the industry: CSTM outperforms 54.49% of its industry peers.
CSTM has a Debt/Equity ratio of 2.53. This is a high value indicating a heavy dependency on external financing.
CSTM's Debt to Equity ratio of 2.53 is on the low side compared to the rest of the industry. CSTM is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Altman-Z 3.25
ROIC/WACC1.26
WACC8.85%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.23 indicates that CSTM should not have too much problems paying its short term obligations.
The Current ratio of CSTM (1.23) is worse than 76.92% of its industry peers.
A Quick Ratio of 0.53 indicates that CSTM may have some problems paying its short term obligations.
CSTM's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CSTM is outperformed by 87.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.53
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

CSTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.49%.
Measured over the past 5 years, CSTM shows a small growth in Earnings Per Share. The EPS has been growing by 3.27% on average per year.
Looking at the last year, CSTM shows a very strong growth in Revenue. The Revenue has grown by 80.43%.
Measured over the past years, CSTM shows a small growth in Revenue. The Revenue has been growing by 4.43% on average per year.
EPS 1Y (TTM)-73.49%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-53.96%
Revenue 1Y (TTM)80.43%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%3.35%

3.2 Future

CSTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 67.98% yearly.
The Revenue is expected to grow by 13.56% on average over the next years. This is quite good.
EPS Next Y167.79%
EPS Next 2Y101.65%
EPS Next 3Y67.98%
EPS Next 5YN/A
Revenue Next Year16.03%
Revenue Next 2Y10.72%
Revenue Next 3Y13.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 53.52, which means the current valuation is very expensive for CSTM.
Based on the Price/Earnings ratio, CSTM is valued a bit cheaper than the industry average as 62.18% of the companies are valued more expensively.
CSTM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 9.29, which indicates a very decent valuation of CSTM.
Based on the Price/Forward Earnings ratio, CSTM is valued cheaply inside the industry as 85.26% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.88. CSTM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 53.52
Fwd PE 9.29
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CSTM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CSTM is cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.42
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

CSTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CSTM may justify a higher PE ratio.
CSTM's earnings are expected to grow with 67.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)16.39
EPS Next 2Y101.65%
EPS Next 3Y67.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CSTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONSTELLIUM SE

NYSE:CSTM (9/19/2025, 2:17:57 PM)

15.52

-0.84 (-5.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners92.96%
Inst Owner Change-0.02%
Ins Owners1.78%
Ins Owner ChangeN/A
Market Cap2.28B
Analysts82.22
Price Target19.38 (24.87%)
Short Float %2.55%
Short Ratio2.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)129.83%
Min EPS beat(2)-17.42%
Max EPS beat(2)277.07%
EPS beat(4)1
Avg EPS beat(4)-188.59%
Min EPS beat(4)-952.86%
Max EPS beat(4)277.07%
EPS beat(8)2
Avg EPS beat(8)-110.02%
EPS beat(12)3
Avg EPS beat(12)-76.02%
EPS beat(16)5
Avg EPS beat(16)-28.44%
Revenue beat(2)1
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-5.83%
Max Revenue beat(2)3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.56%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-3.1%
Revenue beat(12)4
Avg Revenue beat(12)-1.8%
Revenue beat(16)8
Avg Revenue beat(16)0.42%
PT rev (1m)0%
PT rev (3m)10.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)6.91%
EPS NY rev (3m)-3.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)3.93%
Valuation
Industry RankSector Rank
PE 53.52
Fwd PE 9.29
P/S 0.17
P/FCF N/A
P/OCF 9.56
P/B 2.92
P/tB 3.56
EV/EBITDA 5.42
EPS(TTM)0.29
EY1.87%
EPS(NY)1.67
Fwd EY10.77%
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)1.62
OCFY10.47%
SpS90.29
BVpS5.31
TBVpS4.36
PEG (NY)0.32
PEG (5Y)16.39
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 16.83%
ROCE 14.12%
ROIC 11.15%
ROICexc 11.59%
ROICexgc 12.1%
OM 3.72%
PM (TTM) 0.99%
GM 12.18%
FCFM N/A
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Debt/EBITDA 2.49
Cap/Depr 131.4%
Cap/Sales 2.96%
Interest Coverage 6
Cash Conversion 30.1%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.53
Altman-Z 3.25
F-Score7
WACC8.85%
ROIC/WACC1.26
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.49%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-53.96%
EPS Next Y167.79%
EPS Next 2Y101.65%
EPS Next 3Y67.98%
EPS Next 5YN/A
Revenue 1Y (TTM)80.43%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%3.35%
Revenue Next Year16.03%
Revenue Next 2Y10.72%
Revenue Next 3Y13.56%
Revenue Next 5YN/A
EBIT growth 1Y29.69%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year108.99%
EBIT Next 3Y38.47%
EBIT Next 5YN/A
FCF growth 1Y-224.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.65%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%